SB 1454 - This act modifies current law on the use of investigational drugs and devices for individuals with terminal illnesses to include those individuals with life-threatening or severely debilitating conditions or illnesses.
Currently, investigational drugs shall not include Schedule I controlled substances. This act repeals that prohibition.
This act is substantially similar to provisions in SB 1682 (2026, SCS/SB 90 (2025), SB 1767 (2026), SCS/HCS/HBs 1717 & 1643 (2026), SCS/HS/HCS/HBs 3068 & 3049 (2026), and SCS/SB 768 (2024). SARAH HASKINS
- Chamber
- Senate
- Introduced
- Dec 19, 2025
- Last action
- Dec 19, 2025 — Prefiled
- Session
- 2026
- Momentum
- 39 · Low